The role of medical physics experts in clinical trials: A guideline from the European Federation of Organisations for Medical Physics

Natalie Louise Abbott; Stephane Chauvie; Loredana Marcu; Catherine DeJean; Christos Melidis; Rens Wientjes; Anne Gasnier; Albert Lisbona; Marco Luzzara; Lorenzo Nicola Mazzoni; Jim O'Doherty; Efi Koutsouveli; Ane Appelt; Christian Rønn Hansen

doi:10.1016/j.ejmp.2024.104821

The role of medical physics experts in clinical trials: A guideline from the European Federation of Organisations for Medical Physics

Natalie Louise Abbott^*
, Stephane Chauvie
, Loredana Marcu
, Catherine DeJean
, Christos Melidis
, Rens Wientjes
, Anne Gasnier
, Albert Lisbona
, Marco Luzzara
, Lorenzo Nicola Mazzoni
, Jim O'Doherty
, Efi Koutsouveli
, Ane Appelt
, Christian Rønn Hansen

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

1 Downloads (Pure)

Abstract

The EFOMP working group on the Role of Medical Physics Experts (MPEs) in Clinical Trials was established in 2010, with experts from across Europe and different areas of medical physics. Their main aims were: (1) To develop a consensus guidance document for the work MPEs do in clinical trials across Europe. (2) Complement the work by American colleagues in AAPM TG 113 and guidance from National Member Organisations. (3) To cover external beam radiotherapy, brachytherapy, nuclear medicine, molecular radiotherapy, and imaging. This document outlines the main output from this working group. Giving guidance to MPEs, and indeed all Medical Physicists (MP) and MP trainees wishing to work in clinical trials. It also gives guidance to the wider multidisciplinary team, advising where MPEs must legally be involved, as well as highlighting areas where MPEs skills and expertise can really add value to clinical trials.

Original language	English
Article number	104821
Journal	Physica medica
Volume	126
DOIs	https://doi.org/10.1016/j.ejmp.2024.104821
Publication status	Published - Oct 2024

Keywords

Clinical trial
Education and training
Medical imaging
Radiation oncology
Radioprotection

Access to Document

10.1016/j.ejmp.2024.104821

1-s2.0-S1120179724010780-mainFinal published version, 947 KBLicence: Taverne

Cite this

Abbott, N. L., Chauvie, S., Marcu, L., DeJean, C., Melidis, C., Wientjes, R., Gasnier, A., Lisbona, A., Luzzara, M., Mazzoni, L. N., O'Doherty, J., Koutsouveli, E., Appelt, A., & Hansen, C. R. (2024). The role of medical physics experts in clinical trials: A guideline from the European Federation of Organisations for Medical Physics. Physica medica, 126, Article 104821. https://doi.org/10.1016/j.ejmp.2024.104821

@article{b50162c48df642ff94e54498b6f9ad53,

title = "The role of medical physics experts in clinical trials: A guideline from the European Federation of Organisations for Medical Physics",

abstract = "The EFOMP working group on the Role of Medical Physics Experts (MPEs) in Clinical Trials was established in 2010, with experts from across Europe and different areas of medical physics. Their main aims were: (1) To develop a consensus guidance document for the work MPEs do in clinical trials across Europe. (2) Complement the work by American colleagues in AAPM TG 113 and guidance from National Member Organisations. (3) To cover external beam radiotherapy, brachytherapy, nuclear medicine, molecular radiotherapy, and imaging. This document outlines the main output from this working group. Giving guidance to MPEs, and indeed all Medical Physicists (MP) and MP trainees wishing to work in clinical trials. It also gives guidance to the wider multidisciplinary team, advising where MPEs must legally be involved, as well as highlighting areas where MPEs skills and expertise can really add value to clinical trials.",

keywords = "Clinical trial, Education and training, Medical imaging, Radiation oncology, Radioprotection",

author = "Abbott, \{Natalie Louise\} and Stephane Chauvie and Loredana Marcu and Catherine DeJean and Christos Melidis and Rens Wientjes and Anne Gasnier and Albert Lisbona and Marco Luzzara and Mazzoni, \{Lorenzo Nicola\} and Jim O'Doherty and Efi Koutsouveli and Ane Appelt and Hansen, \{Christian R{\o}nn\}",

note = "Publisher Copyright: {\textcopyright} 2024",

year = "2024",

month = oct,

doi = "10.1016/j.ejmp.2024.104821",

language = "English",

volume = "126",

journal = "Physica medica",

issn = "1120-1797",

publisher = "Associazione Italiana di Fisica Medica",

}

Abbott, NL, Chauvie, S, Marcu, L, DeJean, C, Melidis, C, Wientjes, R, Gasnier, A, Lisbona, A, Luzzara, M, Mazzoni, LN, O'Doherty, J, Koutsouveli, E, Appelt, A & Hansen, CR 2024, 'The role of medical physics experts in clinical trials: A guideline from the European Federation of Organisations for Medical Physics', Physica medica, vol. 126, 104821. https://doi.org/10.1016/j.ejmp.2024.104821

TY - JOUR

T1 - The role of medical physics experts in clinical trials

T2 - A guideline from the European Federation of Organisations for Medical Physics

AU - Abbott, Natalie Louise

AU - Chauvie, Stephane

AU - Marcu, Loredana

AU - DeJean, Catherine

AU - Melidis, Christos

AU - Wientjes, Rens

AU - Gasnier, Anne

AU - Lisbona, Albert

AU - Luzzara, Marco

AU - Mazzoni, Lorenzo Nicola

AU - O'Doherty, Jim

AU - Koutsouveli, Efi

AU - Appelt, Ane

AU - Hansen, Christian Rønn

PY - 2024/10

Y1 - 2024/10

N2 - The EFOMP working group on the Role of Medical Physics Experts (MPEs) in Clinical Trials was established in 2010, with experts from across Europe and different areas of medical physics. Their main aims were: (1) To develop a consensus guidance document for the work MPEs do in clinical trials across Europe. (2) Complement the work by American colleagues in AAPM TG 113 and guidance from National Member Organisations. (3) To cover external beam radiotherapy, brachytherapy, nuclear medicine, molecular radiotherapy, and imaging. This document outlines the main output from this working group. Giving guidance to MPEs, and indeed all Medical Physicists (MP) and MP trainees wishing to work in clinical trials. It also gives guidance to the wider multidisciplinary team, advising where MPEs must legally be involved, as well as highlighting areas where MPEs skills and expertise can really add value to clinical trials.

AB - The EFOMP working group on the Role of Medical Physics Experts (MPEs) in Clinical Trials was established in 2010, with experts from across Europe and different areas of medical physics. Their main aims were: (1) To develop a consensus guidance document for the work MPEs do in clinical trials across Europe. (2) Complement the work by American colleagues in AAPM TG 113 and guidance from National Member Organisations. (3) To cover external beam radiotherapy, brachytherapy, nuclear medicine, molecular radiotherapy, and imaging. This document outlines the main output from this working group. Giving guidance to MPEs, and indeed all Medical Physicists (MP) and MP trainees wishing to work in clinical trials. It also gives guidance to the wider multidisciplinary team, advising where MPEs must legally be involved, as well as highlighting areas where MPEs skills and expertise can really add value to clinical trials.

KW - Clinical trial

KW - Education and training

KW - Medical imaging

KW - Radiation oncology

KW - Radioprotection

UR - https://www.scopus.com/pages/publications/85205351014

U2 - 10.1016/j.ejmp.2024.104821

DO - 10.1016/j.ejmp.2024.104821

M3 - Article

AN - SCOPUS:85205351014

SN - 1120-1797

VL - 126

JO - Physica medica

JF - Physica medica

M1 - 104821

ER -

The role of medical physics experts in clinical trials: A guideline from the European Federation of Organisations for Medical Physics

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this